tradingkey.logo

Bioventus Inc

BVS
8.510USD
+0.300+3.65%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
569.95MMarktkapitalisierung
54.31KGV TTM

Bioventus Inc

8.510
+0.300+3.65%

mehr Informationen über Bioventus Inc Unternehmen

Bioventus Inc. is a medical device company. The Company’s portfolio of products is grouped into three areas. Its Pain Treatments include the Knee Osteoarthritis (KOA) area, and Peripheral Nerve Stimulation (PNS) area. Its Surgical Solutions include Ultrasonics, which offers precision bone resection for patients with degenerative spine conditions and spinal deformities, and Bone Graft Substitutes (BGS), which includes a range of products that facilitate optimal bone fusion following a surgical procedure. Its Restorative Therapies comprise Fracture Care that provide low-intensity pulse ultrasound to help patients who suffer from bone fractures that do not heal through traditional methods. It offers a diverse portfolio of products to support physicians in relieving pain and addressing musculoskeletal challenges across indications and clinical areas, including knee, hand and upper extremities, foot and ankle, podiatry, trauma, general surgery, spine and neurosurgery.

Bioventus Inc Informationen

BörsenkürzelBVS
Name des UnternehmensBioventus Inc
IPO-datumFeb 11, 2021
CEOClaypoole (Robert E)
Anzahl der mitarbeiter930
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 11
Addresse4721 Emperor Boulevard, Suite 100
StadtDURHAM
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl27703
Telefon19194746700
Websitehttps://www.bioventus.com/
BörsenkürzelBVS
IPO-datumFeb 11, 2021
CEOClaypoole (Robert E)

Führungskräfte von Bioventus Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Susan M. Stalnecker
Ms. Susan M. Stalnecker
Independent Director
Independent Director
105.96K
+26493.00%
Mr. Guido J. Neels
Mr. Guido J. Neels
Independent Director
Independent Director
85.24K
+26493.00%
Mr. John A. Bartholdson
Mr. John A. Bartholdson
Independent Director
Independent Director
79.62K
+34068.00%
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
Independent Director
Independent Director
76.44K
+26493.00%
Mr. Philip G. Cowdy
Mr. Philip G. Cowdy
Independent Director
Independent Director
11.70K
--
Ms. Mary Katherine (Kay) Ladone
Ms. Mary Katherine (Kay) Ladone
Independent Director
Independent Director
--
--
Ms. Michelle Mcmurry-Heath, M.D., Ph.D.
Ms. Michelle Mcmurry-Heath, M.D., Ph.D.
Independent Director
Independent Director
--
--
Mr. Mark Singleton
Mr. Mark Singleton
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
--
--
Mr. Robert E. Claypoole
Mr. Robert E. Claypoole
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Dr. Ajay Dhankhar, Ph.D.
Dr. Ajay Dhankhar, Ph.D.
Director
Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Susan M. Stalnecker
Ms. Susan M. Stalnecker
Independent Director
Independent Director
105.96K
+26493.00%
Mr. Guido J. Neels
Mr. Guido J. Neels
Independent Director
Independent Director
85.24K
+26493.00%
Mr. John A. Bartholdson
Mr. John A. Bartholdson
Independent Director
Independent Director
79.62K
+34068.00%
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
Independent Director
Independent Director
76.44K
+26493.00%
Mr. Philip G. Cowdy
Mr. Philip G. Cowdy
Independent Director
Independent Director
11.70K
--
Ms. Mary Katherine (Kay) Ladone
Ms. Mary Katherine (Kay) Ladone
Independent Director
Independent Director
--
--

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Pain Treatments
67.18M
48.45%
Surgical solutions
50.17M
36.18%
Restorative Therapies
21.31M
15.37%
Nach RegionUSD
Name
Umsatz
Anteil
United States
123.31M
88.94%
International
15.34M
11.06%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Pain Treatments
67.18M
48.45%
Surgical solutions
50.17M
36.18%
Restorative Therapies
21.31M
15.37%

Aktionärsstatistik

Aktualisiert: Mon, Nov 17
Aktualisiert: Mon, Nov 17
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
EW Healthcare Partners
19.44%
Juniper Investment Company, LLC
10.36%
Smith & Nephew Group plc
9.30%
Nantahala Capital Management, LLC
8.68%
The Vanguard Group, Inc.
4.39%
Andere
47.83%
Aktionäre
Aktionäre
Anteil
EW Healthcare Partners
19.44%
Juniper Investment Company, LLC
10.36%
Smith & Nephew Group plc
9.30%
Nantahala Capital Management, LLC
8.68%
The Vanguard Group, Inc.
4.39%
Andere
47.83%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor/Hedge Fund
22.99%
Venture Capital
19.55%
Investment Advisor
15.76%
Hedge Fund
14.00%
Corporation
9.30%
Individual Investor
2.58%
Research Firm
1.72%
Insurance Company
0.47%
Bank and Trust
0.22%
Andere
13.42%

Institutionelle Beteiligung

Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
319
49.87M
91.76%
-1.55K
2025Q3
324
49.87M
92.42%
+451.64K
2025Q2
315
49.43M
88.24%
+1.39M
2025Q1
300
47.59M
85.68%
-9.15M
2024Q4
302
46.29M
87.45%
+580.76K
2024Q3
303
45.64M
84.02%
-1.26M
2024Q2
271
47.35M
78.83%
+4.38M
2024Q1
269
42.96M
79.86%
-7.88M
2023Q4
267
41.98M
81.20%
+236.50K
2023Q3
256
41.69M
80.71%
+844.38K
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
EW Healthcare Partners
13.02M
19.44%
--
--
Sep 30, 2025
Juniper Investment Company, LLC
6.94M
10.36%
--
--
Sep 30, 2025
Smith & Nephew Group plc
6.23M
9.3%
--
--
Apr 07, 2025
Nantahala Capital Management, LLC
5.81M
8.68%
+529.82K
+10.03%
Sep 30, 2025
The Vanguard Group, Inc.
2.88M
4.3%
+108.48K
+3.92%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
2.81M
4.2%
-6.12K
-0.22%
Sep 30, 2025
Royce Investment Partners
1.26M
1.89%
+170.90K
+15.65%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.10M
1.64%
+45.95K
+4.36%
Sep 30, 2025
American Century Investment Management, Inc.
1.09M
1.63%
-32.95K
-2.93%
Sep 30, 2025
Kent Lake PR LLC
1.00M
1.49%
+650.16K
+185.74%
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Vanguard US Multifactor ETF
0.1%
VictoryShares Small Cap Free Cash Flow ETF
0.1%
Harbor Human Capital Factor US Small Cap ETF
0.09%
Fidelity Enhanced Small Cap ETF
0.09%
iShares Micro-Cap ETF
0.06%
Principal U.S. Small-Cap ETF
0.05%
Vanguard US Value Factor ETF
0.04%
Humankind US Stock ETF
0.03%
WisdomTree US SmallCap Fund
0.03%
Avantis US Small Cap Value ETF
0.03%
Mehr Anzeigen
Vanguard US Multifactor ETF
Anteil0.1%
VictoryShares Small Cap Free Cash Flow ETF
Anteil0.1%
Harbor Human Capital Factor US Small Cap ETF
Anteil0.09%
Fidelity Enhanced Small Cap ETF
Anteil0.09%
iShares Micro-Cap ETF
Anteil0.06%
Principal U.S. Small-Cap ETF
Anteil0.05%
Vanguard US Value Factor ETF
Anteil0.04%
Humankind US Stock ETF
Anteil0.03%
WisdomTree US SmallCap Fund
Anteil0.03%
Avantis US Small Cap Value ETF
Anteil0.03%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI